JP6563975B2 - 防腐性ポリメタクリル酸メチル骨セメント - Google Patents
防腐性ポリメタクリル酸メチル骨セメント Download PDFInfo
- Publication number
- JP6563975B2 JP6563975B2 JP2017100554A JP2017100554A JP6563975B2 JP 6563975 B2 JP6563975 B2 JP 6563975B2 JP 2017100554 A JP2017100554 A JP 2017100554A JP 2017100554 A JP2017100554 A JP 2017100554A JP 6563975 B2 JP6563975 B2 JP 6563975B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- composition
- bone cement
- monomer
- monoperoxydicarboxylic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002639 bone cement Substances 0.000 title claims description 71
- 229920003229 poly(methyl methacrylate) Polymers 0.000 title claims description 26
- 239000004926 polymethyl methacrylate Substances 0.000 title claims description 26
- 230000002421 anti-septic effect Effects 0.000 title claims description 15
- 239000000203 mixture Substances 0.000 claims description 150
- 239000000178 monomer Substances 0.000 claims description 94
- 239000002253 acid Substances 0.000 claims description 88
- 150000003839 salts Chemical class 0.000 claims description 59
- 239000000843 powder Substances 0.000 claims description 56
- 125000004432 carbon atom Chemical group C* 0.000 claims description 33
- 238000006116 polymerization reaction Methods 0.000 claims description 33
- 239000002245 particle Substances 0.000 claims description 30
- 238000010526 radical polymerization reaction Methods 0.000 claims description 29
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 24
- 229920000642 polymer Polymers 0.000 claims description 23
- 229920000620 organic polymer Polymers 0.000 claims description 21
- 238000002156 mixing Methods 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 16
- 102000016938 Catalase Human genes 0.000 claims description 14
- 108010053835 Catalase Proteins 0.000 claims description 14
- 239000003505 polymerization initiator Substances 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 12
- GLVYLTSKTCWWJR-UHFFFAOYSA-N 2-carbonoperoxoylbenzoic acid Chemical compound OOC(=O)C1=CC=CC=C1C(O)=O GLVYLTSKTCWWJR-UHFFFAOYSA-N 0.000 claims description 11
- 125000003118 aryl group Chemical group 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 229920002845 Poly(methacrylic acid) Polymers 0.000 claims description 10
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 9
- 239000003112 inhibitor Substances 0.000 claims description 9
- 210000000988 bone and bone Anatomy 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- 229920001577 copolymer Polymers 0.000 claims description 7
- 159000000003 magnesium salts Chemical group 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 125000005907 alkyl ester group Chemical group 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 230000000379 polymerizing effect Effects 0.000 claims description 6
- WBOQHFMXKCEWSQ-UHFFFAOYSA-N 4-hydroperoxy-4-oxobutanoic acid Chemical compound OOC(=O)CCC(O)=O WBOQHFMXKCEWSQ-UHFFFAOYSA-N 0.000 claims description 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 5
- 230000003115 biocidal effect Effects 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 239000013543 active substance Substances 0.000 claims description 3
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 230000001009 osteoporotic effect Effects 0.000 claims description 3
- 229920000193 polymethacrylate Polymers 0.000 claims description 3
- 239000012966 redox initiator Substances 0.000 claims description 3
- 238000002560 therapeutic procedure Methods 0.000 claims description 3
- 150000001447 alkali salts Chemical class 0.000 claims description 2
- 230000003416 augmentation Effects 0.000 claims description 2
- 239000012876 carrier material Substances 0.000 claims description 2
- 230000007547 defect Effects 0.000 claims description 2
- BOQSSGDQNWEFSX-UHFFFAOYSA-N propan-2-yl 2-methylprop-2-enoate Chemical compound CC(C)OC(=O)C(C)=C BOQSSGDQNWEFSX-UHFFFAOYSA-N 0.000 claims description 2
- 210000003625 skull Anatomy 0.000 claims description 2
- 125000006850 spacer group Chemical group 0.000 claims description 2
- 230000000699 topical effect Effects 0.000 claims description 2
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 claims 1
- WWOYCMCZTZTIGU-UHFFFAOYSA-L magnesium;2-carboxybenzenecarboperoxoate;hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].OOC(=O)C1=CC=CC=C1C([O-])=O.OOC(=O)C1=CC=CC=C1C([O-])=O WWOYCMCZTZTIGU-UHFFFAOYSA-L 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 208000011117 substance-related disease Diseases 0.000 claims 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 39
- 239000004568 cement Substances 0.000 description 20
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- -1 silver ions Chemical class 0.000 description 16
- 150000007513 acids Chemical class 0.000 description 14
- 239000000654 additive Substances 0.000 description 14
- 239000003755 preservative agent Substances 0.000 description 13
- 230000002335 preservative effect Effects 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 11
- 230000000996 additive effect Effects 0.000 description 11
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 11
- 229940125717 barbiturate Drugs 0.000 description 9
- 238000005452 bending Methods 0.000 description 9
- 102000003992 Peroxidases Human genes 0.000 description 8
- 229910052709 silver Inorganic materials 0.000 description 8
- 239000004332 silver Substances 0.000 description 8
- 125000001424 substituent group Chemical group 0.000 description 8
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 7
- 230000009471 action Effects 0.000 description 7
- 239000012736 aqueous medium Substances 0.000 description 7
- 239000000945 filler Substances 0.000 description 7
- 239000000377 silicon dioxide Substances 0.000 description 7
- 235000012239 silicon dioxide Nutrition 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 6
- 239000003086 colorant Substances 0.000 description 6
- 238000007334 copolymerization reaction Methods 0.000 description 6
- 229910001385 heavy metal Inorganic materials 0.000 description 6
- 230000002209 hydrophobic effect Effects 0.000 description 6
- 239000003999 initiator Substances 0.000 description 6
- 125000005397 methacrylic acid ester group Chemical group 0.000 description 6
- 150000002978 peroxides Chemical class 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- DNZPLHRZXUJATK-UHFFFAOYSA-N 2-sulfanylidene-5-[[5-[2-(trifluoromethyl)phenyl]furan-2-yl]methyl]-1,3-diazinane-4,6-dione Chemical compound FC(F)(F)C1=CC=CC=C1C(O1)=CC=C1CC1C(=O)NC(=S)NC1=O DNZPLHRZXUJATK-UHFFFAOYSA-N 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 108040007629 peroxidase activity proteins Proteins 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 229910052723 transition metal Inorganic materials 0.000 description 5
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 4
- 125000001931 aliphatic group Chemical group 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 239000000806 elastomer Substances 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- GYVGXEWAOAAJEU-UHFFFAOYSA-N n,n,4-trimethylaniline Chemical group CN(C)C1=CC=C(C)C=C1 GYVGXEWAOAAJEU-UHFFFAOYSA-N 0.000 description 4
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 4
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 description 4
- RDEIXVOBVLKYNT-VQBXQJRRSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]o Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)C(C)N)N)[C@@H](N)C[C@H]1N.O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-VQBXQJRRSA-N 0.000 description 3
- JUVSRZCUMWZBFK-UHFFFAOYSA-N 2-[n-(2-hydroxyethyl)-4-methylanilino]ethanol Chemical compound CC1=CC=C(N(CCO)CCO)C=C1 JUVSRZCUMWZBFK-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 108700020962 Peroxidase Proteins 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- MCMNRKCIXSYSNV-UHFFFAOYSA-N ZrO2 Inorganic materials O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 3
- 235000011837 pasties Nutrition 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 229910052814 silicon oxide Inorganic materials 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000006150 trypticase soy agar Substances 0.000 description 3
- FRIBMENBGGCKPD-UHFFFAOYSA-N 3-(2,3-dimethoxyphenyl)prop-2-enal Chemical compound COC1=CC=CC(C=CC=O)=C1OC FRIBMENBGGCKPD-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 230000000274 adsorptive effect Effects 0.000 description 2
- 125000002723 alicyclic group Chemical group 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 150000007656 barbituric acids Chemical class 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- JJLJMEJHUUYSSY-UHFFFAOYSA-L copper(II) hydroxide Inorganic materials [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000004179 indigotine Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 150000002736 metal compounds Chemical class 0.000 description 2
- XKBGEWXEAPTVCK-UHFFFAOYSA-M methyltrioctylammonium chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC XKBGEWXEAPTVCK-UHFFFAOYSA-M 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 229920006255 plastic film Polymers 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- UGQZLDXDWSPAOM-UHFFFAOYSA-N pyrrolo[3,4-f]isoindole-1,3,5,7-tetrone Chemical compound C1=C2C(=O)NC(=O)C2=CC2=C1C(=O)NC2=O UGQZLDXDWSPAOM-UHFFFAOYSA-N 0.000 description 2
- 239000004172 quinoline yellow Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000013074 reference sample Substances 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 229940081974 saccharin Drugs 0.000 description 2
- 235000019204 saccharin Nutrition 0.000 description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 229960002317 succinimide Drugs 0.000 description 2
- 150000003624 transition metals Chemical group 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 239000002966 varnish Substances 0.000 description 2
- RPAJSBKBKSSMLJ-DFWYDOINSA-N (2s)-2-aminopentanedioic acid;hydrochloride Chemical class Cl.OC(=O)[C@@H](N)CCC(O)=O RPAJSBKBKSSMLJ-DFWYDOINSA-N 0.000 description 1
- ZEUUPKVZFKBXPW-TWDWGCDDSA-N (2s,3r,4s,5s,6r)-4-amino-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,5s,6r)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol;sulfuric acid Chemical compound OS(O)(=O)=O.N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N ZEUUPKVZFKBXPW-TWDWGCDDSA-N 0.000 description 1
- JHPBZFOKBAGZBL-UHFFFAOYSA-N (3-hydroxy-2,2,4-trimethylpentyl) 2-methylprop-2-enoate Chemical group CC(C)C(O)C(C)(C)COC(=O)C(C)=C JHPBZFOKBAGZBL-UHFFFAOYSA-N 0.000 description 1
- OTSKHUNLOQPIGN-UHFFFAOYSA-N 1,3,5-trimethyl-1,3-diazinane-2,4,6-trione Chemical compound CC1C(=O)N(C)C(=O)N(C)C1=O OTSKHUNLOQPIGN-UHFFFAOYSA-N 0.000 description 1
- SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 description 1
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 description 1
- BHFBSMNSXBNSSK-UHFFFAOYSA-N 10-hydroperoxy-10-oxodecanoic acid Chemical compound OOC(=O)CCCCCCCCC(O)=O BHFBSMNSXBNSSK-UHFFFAOYSA-N 0.000 description 1
- DKCPKDPYUFEZCP-UHFFFAOYSA-N 2,6-di-tert-butylphenol Chemical compound CC(C)(C)C1=CC=CC(C(C)(C)C)=C1O DKCPKDPYUFEZCP-UHFFFAOYSA-N 0.000 description 1
- MIRQGKQPLPBZQM-UHFFFAOYSA-N 2-hydroperoxy-2,4,4-trimethylpentane Chemical compound CC(C)(C)CC(C)(C)OO MIRQGKQPLPBZQM-UHFFFAOYSA-N 0.000 description 1
- XRXANEMIFVRKLN-UHFFFAOYSA-N 2-hydroperoxy-2-methylbutane Chemical compound CCC(C)(C)OO XRXANEMIFVRKLN-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- JZXVADSBLRIAIB-UHFFFAOYSA-N 2-pyrrolidin-2-ylethanol Chemical compound OCCC1CCCN1 JZXVADSBLRIAIB-UHFFFAOYSA-N 0.000 description 1
- KZMRYBLIGYQPPP-UHFFFAOYSA-M 3-[[4-[(2-chlorophenyl)-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]-n-ethylanilino]methyl]benzenesulfonate Chemical compound C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)Cl)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 KZMRYBLIGYQPPP-UHFFFAOYSA-M 0.000 description 1
- IEZTZCXBBTUQMD-UHFFFAOYSA-N 5-ethyl-1-phenyl-1,3-diazinane-2,4,6-trione Chemical compound O=C1C(CC)C(=O)NC(=O)N1C1=CC=CC=C1 IEZTZCXBBTUQMD-UHFFFAOYSA-N 0.000 description 1
- HKPDOIFMZWCYRI-UHFFFAOYSA-N 8-hydroperoxy-8-oxooctanoic acid Chemical compound OOC(=O)CCCCCCC(O)=O HKPDOIFMZWCYRI-UHFFFAOYSA-N 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 238000004438 BET method Methods 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical group CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 239000004343 Calcium peroxide Substances 0.000 description 1
- 229910021503 Cobalt(II) hydroxide Inorganic materials 0.000 description 1
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 229910052688 Gadolinium Inorganic materials 0.000 description 1
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910001257 Nb alloy Inorganic materials 0.000 description 1
- SCKXCAADGDQQCS-UHFFFAOYSA-N Performic acid Chemical group OOC=O SCKXCAADGDQQCS-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 229920002413 Polyhexanide Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229910000676 Si alloy Inorganic materials 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- WDLRUFUQRNWCPK-UHFFFAOYSA-N Tetraxetan Chemical compound OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1 WDLRUFUQRNWCPK-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- WAIPAZQMEIHHTJ-UHFFFAOYSA-N [Cr].[Co] Chemical compound [Cr].[Co] WAIPAZQMEIHHTJ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 150000001409 amidines Chemical class 0.000 description 1
- YVPYQUNUQOZFHG-UHFFFAOYSA-N amidotrizoic acid Chemical compound CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I YVPYQUNUQOZFHG-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 1
- 235000019402 calcium peroxide Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960001200 clindamycin hydrochloride Drugs 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000010952 cobalt-chrome Substances 0.000 description 1
- PKSIZOUDEUREFF-UHFFFAOYSA-N cobalt;dihydrate Chemical compound O.O.[Co] PKSIZOUDEUREFF-UHFFFAOYSA-N 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 229940116318 copper carbonate Drugs 0.000 description 1
- 239000004121 copper complexes of chlorophylls and chlorophyllins Substances 0.000 description 1
- ZKXWKVVCCTZOLD-FDGPNNRMSA-N copper;(z)-4-hydroxypent-3-en-2-one Chemical compound [Cu].C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O ZKXWKVVCCTZOLD-FDGPNNRMSA-N 0.000 description 1
- SEKCXMNFUDONGJ-UHFFFAOYSA-L copper;2-ethylhexanoate Chemical compound [Cu+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O SEKCXMNFUDONGJ-UHFFFAOYSA-L 0.000 description 1
- VZWHXRLOECMQDD-UHFFFAOYSA-L copper;2-methylprop-2-enoate Chemical compound [Cu+2].CC(=C)C([O-])=O.CC(=C)C([O-])=O VZWHXRLOECMQDD-UHFFFAOYSA-L 0.000 description 1
- GEZOTWYUIKXWOA-UHFFFAOYSA-L copper;carbonate Chemical compound [Cu+2].[O-]C([O-])=O GEZOTWYUIKXWOA-UHFFFAOYSA-L 0.000 description 1
- AEJIMXVJZFYIHN-UHFFFAOYSA-N copper;dihydrate Chemical compound O.O.[Cu] AEJIMXVJZFYIHN-UHFFFAOYSA-N 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- MRIZMKJLUDDMHF-UHFFFAOYSA-N cumene;hydrogen peroxide Chemical compound OO.CC(C)C1=CC=CC=C1 MRIZMKJLUDDMHF-UHFFFAOYSA-N 0.000 description 1
- 125000006165 cyclic alkyl group Chemical group 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- LIKFHECYJZWXFJ-UHFFFAOYSA-N dimethyldichlorosilane Chemical compound C[Si](C)(Cl)Cl LIKFHECYJZWXFJ-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
- 150000002251 gadolinium compounds Chemical class 0.000 description 1
- 239000004120 green S Substances 0.000 description 1
- 159000000011 group IA salts Chemical class 0.000 description 1
- 229910052735 hafnium Inorganic materials 0.000 description 1
- VBJZVLUMGGDVMO-UHFFFAOYSA-N hafnium atom Chemical compound [Hf] VBJZVLUMGGDVMO-UHFFFAOYSA-N 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000011256 inorganic filler Substances 0.000 description 1
- 229910003475 inorganic filler Inorganic materials 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 229910001172 neodymium magnet Inorganic materials 0.000 description 1
- RJSRQTFBFAJJIL-UHFFFAOYSA-N niobium titanium Chemical compound [Ti].[Nb] RJSRQTFBFAJJIL-UHFFFAOYSA-N 0.000 description 1
- KPADFPAILITQBG-UHFFFAOYSA-N non-4-ene Chemical compound CCCCC=CCCC KPADFPAILITQBG-UHFFFAOYSA-N 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphonic acid group Chemical group P(O)(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000011164 primary particle Substances 0.000 description 1
- RZWMDOQSXWAAMC-UHFFFAOYSA-N propyl 2-methylbut-2-enoate Chemical compound CCCOC(=O)C(C)=CC RZWMDOQSXWAAMC-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229910000938 samarium–cobalt magnet Inorganic materials 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 1
- 125000005372 silanol group Chemical group 0.000 description 1
- 150000003378 silver Chemical class 0.000 description 1
- 229940100890 silver compound Drugs 0.000 description 1
- 150000003379 silver compounds Chemical class 0.000 description 1
- FJOLTQXXWSRAIX-UHFFFAOYSA-K silver phosphate Chemical compound [Ag+].[Ag+].[Ag+].[O-]P([O-])([O-])=O FJOLTQXXWSRAIX-UHFFFAOYSA-K 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical group S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 229910001936 tantalum oxide Inorganic materials 0.000 description 1
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 150000003573 thiols Chemical group 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960004477 tobramycin sulfate Drugs 0.000 description 1
- 229910001428 transition metal ion Inorganic materials 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- JABYJIQOLGWMQW-UHFFFAOYSA-N undec-4-ene Chemical compound CCCCCCC=CCCC JABYJIQOLGWMQW-UHFFFAOYSA-N 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 229960001572 vancomycin hydrochloride Drugs 0.000 description 1
- LCTORFDMHNKUSG-XTTLPDOESA-N vancomycin monohydrochloride Chemical compound Cl.O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 LCTORFDMHNKUSG-XTTLPDOESA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- 229910000859 α-Fe Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/0047—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L24/0073—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C409/00—Peroxy compounds
- C07C409/24—Peroxy compounds the —O—O— group being bound between a >C=O group and hydrogen, i.e. peroxy acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/14—Peroxides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- C08L33/04—Homopolymers or copolymers of esters
- C08L33/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, which oxygen atoms are present only as part of the carboxyl radical
- C08L33/10—Homopolymers or copolymers of methacrylic acid esters
- C08L33/12—Homopolymers or copolymers of methyl methacrylate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
- A61L2300/212—Peroxy acids, peracids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F212/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
- C08F212/02—Monomers containing only one unsaturated aliphatic radical
- C08F212/04—Monomers containing only one unsaturated aliphatic radical containing one ring
- C08F212/06—Hydrocarbons
- C08F212/08—Styrene
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2312/00—Crosslinking
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Composite Materials (AREA)
- Materials For Medical Uses (AREA)
Description
(a)ペーストAは、各々ペーストAの総重量に対して、
(a1)少なくとも1種のラジカル重合用モノマー、特にその15〜85重量%、好ましくはその20〜70重量%、より好ましくはその25〜60重量%、特に好ましくはその25〜50重量%、
(a2)(a1)に可溶である少なくとも1種の有機ポリマー、特にその5〜50重量%、好ましくはその10〜40重量%、特に好ましくはその20〜30重量%、及び
(a3)任意に、少なくとも1種の重合阻害剤、特にその0.05〜1.0重量%、及び
(a4)レドックス開始剤系の少なくとも1種の成分、特にその0.1〜10重量%、好ましくはその0.01〜8重量%、特に好ましくはその0.01〜5重量%、
並びに、任意に、(a1)に不溶である放射線不透過性物質及び/又は充填剤などの更なる成分
を含み、
(b)ペーストBは、各々ペーストBの総重量に対して、
(b1)少なくとも1種のラジカル重合用モノマー、特にその15〜85重量%、好ましくはその20〜70重量%、より好ましくはその25〜60重量%、特に好ましくはその25〜50重量%、
(b2)(b1)に可溶である少なくとも1種の有機ポリマー、特にその5〜50重量%、好ましくはその10〜40重量%、特に好ましくはその20〜30重量%、及び
(b3)少なくとも1種の重合促進剤、特にその0.0005〜0.5重量%、
並びに、任意に、更なる成分、(b1)に不溶である放射線不透過性物質及び/又は充填剤
を含み、
ペーストA又はBの少なくとも一方は、成分(a5)若しくは(b4)として、又はペーストAとBの両方は、成分(a5)及び(b4)として、少なくともある含有量のモノペルオキシジカルボン酸の薬理学的に許容される塩、特に組成物の総量に対してその0.5〜6.0重量%、好ましくはその1.5〜5重量%、特に好ましくはその2〜4.5重量%、より好ましくはその3.0〜4.0重量%を含む。
(c)粉体成分Cは、各々粉体成分Cの総重量に対して、
(c1)少なくとも1種の粉末ポリ(メタ)アクリラート、特にその1〜95重量%、好ましくは最高85重量%、特に好ましくは50〜80重量%、
(c2)少なくとも1種の粉末放射線不透過性物質、特にその3〜60重量%、好ましくはその3〜30重量%、特に好ましくはその5〜15重量%、及び
(c3)少なくとも1種の重合開始剤、特にその0.01〜10重量%、好ましくはその0.01〜8重量%、特に好ましくはその0.01〜5重量%、更なる好ましくはその0.4〜3.0重量%、並びに、任意に、粉末充填剤などの更なる成分
を含み、
(d)モノマー成分Dは、各々モノマー成分Dの総重量に対して、
(d1)少なくとも1種のラジカル重合用モノマー、特にその80〜99.9995重量パーセント、好ましくはその80〜99重量%、
(d2)任意に、少なくとも1種の重合阻害剤、特にその0.1〜1.5重量%、
(d3)任意に、(d1)に可溶である少なくとも1種の有機ポリマー、特にその最高19重量%、
(d4)少なくとも1種の重合促進剤、特にその0.0005〜1.5重量%、好ましくはその0.1〜1.5重量%、
並びに、任意に、(d1)に不溶である放射線不透過性物質及び/又は充填剤、及び/又は添加剤などの更なる成分
を含み、
粉体成分Cは、成分(c4)として、ある含有量のモノペルオキシジカルボン酸の薬理学的に許容される塩、特に組成物の総量に対してその0.5〜6.0重量%、好ましくはその1.5〜5重量%、特に好ましくはその2〜4.5重量%、より好ましくはその3.0〜4.0重量%を含む。
ISO5833による機械的パラメータの測定
75%過酸化ジベンゾイルを重合開始剤として(アクゾノーベルから入手した、25重量%水で減感されたBPO、バッチ番号2612211601)、マグネシウムモノペルオキシ−o−フタラート六水和物をモノペルオキシジカルボン酸塩として(工業純度、含有量約80%、シグマアルドリッチから入手、製品番号69868、粒径<250μm)、二酸化ジルコニウムを放射線不透過性物質として(S.Goldmannから入手、バッチ番号FB100856)、ポリ(メタクリル酸メチル−コ−アクリル酸メチル)(Evonikから入手したPMMA−コ−MA、バッチ番号310HDF129)をコポリマー成分として使用して、下表に示すセメント粉体を製造する。
ISO5833は、50MPa以上の曲げ強度、1,800MPa以上の曲げ弾性率、及び70MPa以上の圧縮強度を必要とする。試験体を機械的性質の試験のためにISO5833に従って製造した。
抗菌効果をJIS Z2801(日本工業規格)に沿ったフィルム接触法によって試験した。基準実施例1及び発明実施例2〜5のセメントを使用して、サイズ50mm×50mm×3mmの帯状セメント試験体を各実施例から3試験体作製した。試験体の表面を70重量%エタノール水溶液で消毒した。黄色ブドウ球菌(Staphylococcus aureus)ATCC6538を試験菌として使用した。試験菌を5重量%血液溶液(0.9%塩化ナトリウム水溶液中の5重量%脱線維素ヒツジ血液)に接種した。各例において、濃度0.5〜2.0×106cfu/mlの試験菌の懸濁液0.2mlを試験体表面に塗布した。この結果、菌添加量は1.0〜4.0×105cfu/mlになった。試験体表面とプラスチックフィルムの距離が約100μmになるようにプラスチックフィルムを菌懸濁液上に置いた。接種した試験体を飽和蒸気雰囲気で36±1℃で24時間インキュベートした。次いで、菌を各々10ml生理食塩水を用いてPEバッグ中で剥離した。菌懸濁液をTSAプレート(トリプチケース(tripticase)ソイ寒天)上にまいた。次いで、TSAプレートを36±1℃で40〜48時間インキュベートした。次いで、生成したコロニーの数をコロニー計数器で数えた。1試験体当たりの菌数を希釈を考慮して求めた。各実施例の3個の試験体の菌数の平均を求め、減少率を基準試料を考慮して計算した。
ここで、
c:インキュベート試験体表面のlog10菌数の算術平均
d:インキュベート基準試料体表面のlog10菌数の算術平均
Claims (22)
- 骨セメントとして使用するための組成物であって、前記組成物は硬化可能であり、前記組成物がモノペルオキシジカルボン酸の薬理学的に許容される塩を含み、前記モノペルオキシジカルボン酸の前記塩が水の存在下で前記組成物から溶解することができ、
前記組成物が防腐性ポリメタクリル酸メチル骨セメントであることを特徴とする、組成物。 - 前記モノペルオキシジカルボン酸の前記塩がアルカリ土類塩又はアルカリ塩であることを特徴とする、請求項1に記載の組成物。
- アルカリ土類塩がマグネシウム塩であることを特徴とする、請求項1又は2に記載の組成物。
- 前記モノペルオキシジカルボン酸の前記塩がメタクリル酸メチルに室温で不溶であることを特徴とする、請求項1から3のいずれか一項に記載の組成物。
- 前記組成物中の前記モノペルオキシジカルボン酸の前記塩が粉体の形態で使用され、前記粉体は平均粒径が250μm以下であることを特徴とする、請求項1から4のいずれか一項に記載の組成物。
- 前記モノペルオキシジカルボン酸の前記塩が、カタラーゼ酵素によって水溶液中で室温で5分以内に分解されないことを特徴とする、請求項1から5のいずれか一項に記載の組成物。
- 前記組成物の総量に対して0.5重量%〜6.0重量%の前記モノペルオキシジカルボン酸の前記塩を含むことを特徴とする、請求項1から6のいずれか一項に記載の組成物。
- 前記モノペルオキシジカルボン酸が、モノペルオキシフタル酸、モノペルオキシグルタル酸、モノペルオキシコハク酸及びモノペルオキシシクロヘキシルジカルボン酸の群の少なくとも1つの要素から選択されることを特徴とする、請求項1から7のいずれか一項に記載の組成物。
- 前記モノペルオキシジカルボン酸がモノペルオキシフタル酸であることを特徴とする、請求項8に記載の組成物。
- 前記組成物がモノペルオキシフタル酸のマグネシウム塩を含むことを特徴とする、請求項8又は9のいずれか一項に記載の組成物。
- 前記組成物が少なくとも1種のラジカル重合用モノマー及び少なくとも1種の有機ポリマーを含み、前記ポリマーが前記モノマーに可溶であることを特徴とする、請求項1から10のいずれか一項に記載の組成物。
- 有機ポリマーが、1〜20個のC原子をアルキル基中に各々独立に有し、6〜14個のC原子をアリール基中に各々独立に有し、6〜14個のC原子をアリールアルキル基中に各々独立に有し、1〜10個のC原子をアルキルエステル基中に各々独立に有する、ポリ(アルキル−2−アクリル酸アルキルエステル)、ポリ(アリール−2−アクリル酸アルキルエステル)、ポリ(アリールアルキル−2−アクリル酸アルキルエステル)、又は前記ポリマーの少なくとも2種を含む混合物から選択されることを特徴とする、請求項1から11のいずれか一項に記載の組成物。
- 前記有機ポリマーが、ポリ(メタクリル酸メチルエステル)、ポリ(メタクリル酸エチルエステル)、ポリ(メチルメタクリル酸プロピルエステル)、ポリ(メタクリル酸イソプロピルエステル)、ポリ(メタクリル酸メチル−コ−アクリル酸メチル)、ポリ(スチレン−コ−メタクリル酸メチル)、前記化合物のコポリマー、及び前記ポリマーの少なくとも2種の混合物の群から選択されることを特徴とする、請求項11又は12のいずれか一項に記載の組成物。
- 前記モノマーが、1〜20個のC原子をアルキル基中に各々独立に有し、6〜14個のC原子をアリール基中に各々独立に有し、6〜14個のC原子をアリールアルキル基中に各々独立に有し、1〜10個のC原子をアルキルエステル基中に各々独立に有する、少なくとも1種の2−アルキル−アクリル酸アルキルエステル、2−アリール−アクリル酸アルキルエステル、2−アリールアルキル−アクリル酸アルキルエステル、又は前記モノマーの少なくとも2種を含む混合物から選択されることを特徴とする、請求項10から13のいずれか一項に記載の組成物。
- 前記有機ポリマーが、少なくとも1種のポリ(メタクリル酸メチルエステル)(PMMA)又はポリ(メタクリル酸メチルエステルコポリマー)、及びモノマーとしてメタクリル酸メチルエステル(MMA)を含むことを特徴とする、請求項11から14のいずれか一項に記載の組成物。
- ペーストA及びペーストBを含むキットであって、
(a)ペーストAが、
(a1)少なくとも1種のラジカル重合用モノマー、
(a2)(a1)に可溶である少なくとも1種の有機ポリマー、
(a3)任意に、少なくとも1種の重合阻害剤、及び
(a4)レドックス開始剤系の少なくとも1種の成分
を含み、
(b)ペーストBが、
(b1)少なくとも1種のラジカル重合用モノマー、
(b2)(b1)に可溶である少なくとも1種の有機ポリマー、及び
(b3)少なくとも1種の重合促進剤
を含み、
前記ペーストA又はBの少なくとも一方が、成分(a5)又は(b4)として、モノペルオキシジカルボン酸の薬理学的に許容される塩を含む、
防腐性ポリメタクリル酸メチル骨セメントを得ることができるキット。 - 粉体成分C及び液体モノマー成分Dを含むキットであって、
(c)粉体成分Cが、
(c1)少なくとも1種の粉末ポリ(メタ)アクリラート、
(c2)少なくとも1種の粉末放射線不透過性物質、
(c3)少なくとも1種の重合開始剤
を含み、
(d)モノマー成分Dが、
(d1)少なくとも1種のラジカル重合用モノマー、
(d2)任意に、少なくとも1種の重合阻害剤、
(d3)任意に、(d1)に可溶である少なくとも1種の有機ポリマー、及び
(d4)少なくとも1種の重合促進剤
を含み、
粉体成分Cが、成分(c4)として、モノペルオキシジカルボン酸の薬理学的に許容される塩を含む、
防腐性ポリメタクリル酸メチル骨セメントを得ることができるキット。 - 請求項1から15のいずれか一項に記載の組成物を重合し、又は請求項16に記載のペーストAとBを混合し、又は請求項17に記載の粉体成分Cとモノマー成分Dを混合する工程を有する、硬化性骨セメントの製造方法。
- 請求項1から15のいずれか一項に記載の組成物を重合し、又は、請求項16に記載のペーストAとBを含む混合物もしくは請求項17に記載の粉体成分Cとモノマー成分Dの混合物を重合する工程を有する硬化性骨セメントの製造方法であって、
前記硬化性骨セメントが、全組成物に対して0.5重量%〜6重量%の含有量の前記モノペルオキシジカルボン酸の前記薬理学的に許容される塩を含む、硬化性骨セメントの製造方法。 - 前記モノペルオキシジカルボン酸の前記塩が水の存在下で硬化中に前記組成物から溶解し、前記モノペルオキシジカルボン酸がカタラーゼ酵素によって5分以内に分解されないことを特徴とする、請求項19に記載の硬化性骨セメントの製造方法。
- 請求項1から15のいずれか一項に記載の組成物を重合し、又は請求項16に記載のペーストAとBを混合した後で重合し、若しくは請求項17に記載の粉体成分Cとモノマー成分Dを混合した後で重合する工程を有する、成形体の製造方法。
- 一次全関節内部人工器官の機械的固定、修正全関節内部人工器官の機械的固定、骨粗鬆症骨組織の増強、骨空洞の充填、大腿骨形成術、スペーサの製造、関節内部人工器官の機械的固定、あるいは頭蓋骨欠損の被覆のための移植片、防腐性移植片、修正移植片として用いられる骨セメントを製造するため、又は、局所抗生物質療法用担体材料や薬学的活性物質の局所放出用担体材料の製造のために用いられる骨セメントを製造するための、請求項1から15のいずれか一項に記載の組成物又は請求項16若しくは17に記載のキットの使用。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102016212091.3 | 2016-07-04 | ||
DE102016212091.3A DE102016212091A1 (de) | 2016-07-04 | 2016-07-04 | Antiseptischer Polymethylmethacrylat-Knochenzement |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018011939A JP2018011939A (ja) | 2018-01-25 |
JP6563975B2 true JP6563975B2 (ja) | 2019-08-21 |
Family
ID=58632180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017100554A Expired - Fee Related JP6563975B2 (ja) | 2016-07-04 | 2017-05-22 | 防腐性ポリメタクリル酸メチル骨セメント |
Country Status (7)
Country | Link |
---|---|
US (1) | US10322207B2 (ja) |
EP (1) | EP3266473A1 (ja) |
JP (1) | JP6563975B2 (ja) |
CN (1) | CN107569715B (ja) |
AU (1) | AU2017202795B2 (ja) |
CA (1) | CA2965055C (ja) |
DE (1) | DE102016212091A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020163241A1 (en) * | 2019-02-04 | 2020-08-13 | Armis Biopharma, Inc. | Methods and devices to reduce the risk of infection |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3234194A (en) * | 1963-06-12 | 1966-02-08 | Du Pont | Methyl methacrylate polymer-in-monomer polymerization in the presence of a peroxymaleate and an amine |
US3827933A (en) * | 1972-04-03 | 1974-08-06 | Du Pont | Filled polymethyl methacrylate article and a process for its manufacture |
NO146306C (no) | 1980-12-09 | 1982-09-08 | Tor Christiansen | Bensement og anvendelse derav. |
DE3245956A1 (de) | 1982-12-11 | 1984-06-14 | Beiersdorf Ag, 2000 Hamburg | Chirurgisches material |
DE3426792A1 (de) * | 1984-07-20 | 1986-01-23 | Degussa Ag, 6000 Frankfurt | Verfahren zur herstellung von monoperoxydicarbonsaeuren und deren salze |
ATE88324T1 (de) | 1984-12-28 | 1993-05-15 | Johnson Matthey Plc | Antimikrobielle zusammensetzungen. |
DE3730921A1 (de) | 1987-09-15 | 1989-03-23 | Degussa | Hitzehaertbare dentalmassen |
US5192532A (en) * | 1989-10-13 | 1993-03-09 | The Procter & Gamble Company | Oral compositions containing monoperoxy acids |
DE19508827A1 (de) * | 1995-03-11 | 1996-09-12 | Bode Chemie Gmbh & Co | Wund- und Schleimhautantiseptikum |
DE19808962C2 (de) * | 1998-03-04 | 2002-03-28 | Bode Chemie Gmbh & Co Kg | Wirkstoffkombinationen und Desinfektionsmittel, Konservierungsmittel und Antiseptika dieselben enthaltend |
DE10043151A1 (de) | 2000-08-31 | 2002-03-28 | Peter Steinruecke | Knochenzement mit antimikrobieller Wirksamkeit |
DE10332680A1 (de) | 2003-07-18 | 2005-02-17 | Biomet Deutschland Gmbh | Verwendung von antiseptischen Wirkstoffen in PMMA-Knochenzementen |
WO2005094756A1 (en) * | 2004-03-11 | 2005-10-13 | Dentsply Detrey Gmbh | Laser curable polymerisable composition for the protection of hard tissue |
DE102007050762B3 (de) | 2007-10-22 | 2009-05-07 | Heraeus Medical Gmbh | Pastenförmiger Polymethylmethacrylat-Knochenzement und seine Verwendung |
DE102007052116B4 (de) | 2007-10-22 | 2013-02-21 | Heraeus Medical Gmbh | Einkomponenten-Knochenzementpasten, deren Verwendung und Verfahren zu deren Aushärtung |
DE102008030312A1 (de) | 2008-06-30 | 2010-01-14 | Heraeus Medical Gmbh | PMMA-Paste |
DE102009005534B3 (de) * | 2008-12-18 | 2010-04-01 | Heraeus Medical Gmbh | Sporozide Zusammensetzungen und deren Verwendung |
DE102009036481A1 (de) * | 2009-08-07 | 2011-02-10 | Nightec Gmbh & Co. Kg | Photolumineszierendes Granulat und Verfahren zu dessen Herstellung |
DE102010005956B4 (de) | 2010-01-27 | 2011-09-01 | Heraeus Medical Gmbh | Dreikomponentenknochenzement und dessen Verwendung |
DE102010024653B4 (de) | 2010-06-22 | 2012-06-21 | Heraeus Medical Gmbh | Kit zur Herstellung von Knochenzement und Verwendung dieses Kits |
DE102012022134A1 (de) * | 2012-11-13 | 2014-05-15 | Heraeus Medical Gmbh | Polymethylmethacrylat-Knochenzement |
DE102012022419A1 (de) * | 2012-11-16 | 2014-05-22 | Heraeus Medical Gmbh | Antiseptischer Polymethylmethacrylat-Knochenzement |
DE102014105267A1 (de) * | 2014-04-14 | 2015-10-15 | Heraeus Medical Gmbh | Polymethylmethacrylat-Knochenzement |
-
2016
- 2016-07-04 DE DE102016212091.3A patent/DE102016212091A1/de not_active Withdrawn
-
2017
- 2017-04-19 EP EP17167025.0A patent/EP3266473A1/de not_active Withdrawn
- 2017-04-24 CA CA2965055A patent/CA2965055C/en active Active
- 2017-04-27 AU AU2017202795A patent/AU2017202795B2/en not_active Ceased
- 2017-05-22 JP JP2017100554A patent/JP6563975B2/ja not_active Expired - Fee Related
- 2017-06-29 US US15/637,456 patent/US10322207B2/en active Active
- 2017-07-04 CN CN201710538357.9A patent/CN107569715B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN107569715B (zh) | 2020-12-04 |
DE102016212091A1 (de) | 2018-01-04 |
JP2018011939A (ja) | 2018-01-25 |
AU2017202795A1 (en) | 2018-01-18 |
CN107569715A (zh) | 2018-01-12 |
AU2017202795B2 (en) | 2018-09-06 |
CA2965055A1 (en) | 2018-01-04 |
US10322207B2 (en) | 2019-06-18 |
US20180000984A1 (en) | 2018-01-04 |
EP3266473A1 (de) | 2018-01-10 |
CA2965055C (en) | 2021-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5698075B2 (ja) | ペースト様骨セメント | |
US9987392B2 (en) | Kit for preparing a paste-like bone cement | |
US9408944B2 (en) | Paste-like bone cement | |
JP6563975B2 (ja) | 防腐性ポリメタクリル酸メチル骨セメント | |
JP6253694B2 (ja) | 防腐性ポリメチルメタクリレート骨セメント | |
CN107029278B (zh) | 抗菌聚甲基丙烯酸甲酯骨接合剂 | |
AU2013200298B2 (en) | Paste-like bone cement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180320 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20180614 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180817 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190108 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190329 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190625 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190625 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190709 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190725 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6563975 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |